View COVID-19 Resources

Medicaid Coverage Gap Resources

View Health Equity Resources

July 2021

Showing 21 of 841 Items
Sort By:
Webinar & Presentations

This presentation examines the affect of the COVID-19 pandemic on historically under-served populations and strategies to increase Medicaid outreach and enrollment within these communities.

Report

This report assesses racial disparities in the quality of inpatient care using 11 patient safety indicators that measure rates of adverse patient safety events of hospital-acquired illnesses or injuries.

Report

This report examines how a public option that typically pays Medicare rates would considerably reduce the cost of increasing coverage in the Medicaid gap.

Commentary

This commentary explains how increased flexibility in the delivery and payment of telehealth across many coverage programs, but particularly in Medicaid and CHIP, throughout the COVID-19 pandemic has been a significant shift for some states. Many state officials are considering if and how to adapt rapidly implemented telehealth policies as the nation emerges from the public health emergency. 

Commentary

This commentary examines how in late June, the U.S. Department of Health and Human Services (HHS) issued its first proposed rule governing the health insurance markets and marketplaces.

Blog

This blog describes how the American Rescue Plan Act expanded access to affordable health insurance coverage in a variety of ways.

Commentary

This commentary explains how since March 2020, many states have rapidly leveraged federal and state flexibilities under the public health emergency to expand telehealth capabilities and reimbursement through both public and private payers.

Commentary

This commentary examines how Washington implemented the nation’s first public option for the 2021 plan year and in the first six months of 2021, states made significant progress in advancing public option proposals, with public option legislation advancing in Colorado, Nevada, and Oregon.

Podcast

This podcast covers how effective data measurement is critical for Medicaid programs seeking to advance health equity and better understand different experiences of populations served by the program.

Graphic

This graphic illustrates how federal guidance has prompted lawmakers in a number of states to introduce legislation prohibiting businesses from requiring COVID-19 vaccinations as a condition of work.

Commentary

This commentary explains the federal government’s goal of reducing new HIV infections by 90% by 2030, the CDC has identified two policy strategies that states can employ for HIV prevention – provision of Pre-Exposure Prophylaxis medication and availability of Syringe Service/Exchange Programs.

Commentary

07.2021 /

This expert perspective summarizes the Interim Final Rule (IFR) of the No Surprises Act, the comprehensive federal law banning balance bills in emergency and certain non-emergency settings.

Commentary

This commentary analyzes how the U.S. Departments of Health & Human Services and Treasury have released a proposed rule governing the Affordable Care Act health insurance marketplaces and insurance standards for the plan year 2022.

Commentary

This commentary explains how rising health care costs and increased consolidation of hospitals and provider groups into large health systems have led states into exploring ways to contain costs and provide oversight of the growing market power of large hospitals.

Report

This report examines how governments and organizations adopt community engagement approaches to collaborate and share power with communities that experience health inequities.

Report

This report examines the U.S. Census Bureau’s Household Pulse Survey to study the relationship between the COVID-19 pandemic and mental health burdens for the United States’ adult population.

Commentary

This commentary examines how recent approval of the Alzheimer’s drug Aduhelm under the U.S. Food & Drug Administration’s Accelerated Approval Program is controversial for a range of reasons, including its projected impact on state Medicaid budgets which will be required to cover the drug, priced at $56,000 a year, despite inconclusive evidence of its clinical effectiveness. 

Chart

This chart details the amounts and required oversight of COVID-19 federal funds allocated to hospitals, providers, and states by the Families First Coronavirus Response Act (Families First Act), the Coronavirus Aid, Relief, and Economic Security Act (CARES Act), the Paycheck Protection Program and Health Care Enhancement Act (HR 266), the Consolidated Appropriations Act, 2021, and the American Rescue Plan Act of 2021.

Commentary

This commentary demonstrates how data analysis is an essential tool for advancing health and racial equity.

Blog

This blog explains the harm reduction public health approach that aims to reduce harms related to substance use by treating people with dignity and compassion.

Commentary

This commentary tells the story of Ben, born with cerebral palsy, whose Medicaid coverage has helped him access a wheelchair and other essential equipment.

ADVANCED SEARCH

  • Sort By

  • Topic(s)